INSIGHTS ON DRUG DEVELOPMENT

• Enable Low Volume Delivery Of Proteins In Aqueous Solutions

  Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

• Making Accelerated Predictive Stability Studies Even Faster With Software

  Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.

• An Integrated Analytical Approach To Lipase Risk Management In Biologics Development

  Conventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors examine why functional activity data are essential for managing polysorbate-related stability risk in biologics development.

• CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

  Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

• Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development

  7/23/2026

  Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

• Spray Dried Biologics For Injectable Dosage Forms

  5/15/2026

  Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

• Matrix Approach Enhances Potency Assay Development For ATMPs

  12/22/2025

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• Best Practices For Analysis Of In Vitro Transcribed (IVT) mRNA

  11/20/2025

  Learn best practices for high-resolution analysis of IVT RNA using automated capillary electrophoresis. Improve accuracy and precision in quantifying critical quality attributes.

• What Are ATMPs And Why Do They Matter?

  3/28/2025

  Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.